These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37544025)

  • 1. Telmisartan inhibits microglia-induced neurotoxic A1 astrocyte conversion via PPARγ-mediated NF-κB/p65 degradation.
    Quan W; Xu CS; Li XC; Yang C; Lan T; Wang MY; Yu DH; Tang F; Wang ZF; Li ZQ
    Int Immunopharmacol; 2023 Oct; 123():110761. PubMed ID: 37544025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan ameliorates Aβ oligomer-induced inflammation via PPARγ/PTEN pathway in BV2 microglial cells.
    Wang ZF; Li J; Ma C; Huang C; Li ZQ
    Biochem Pharmacol; 2020 Jan; 171():113674. PubMed ID: 31634455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor effects of telmisartan in glioma-astrocyte non-contact co-cultures: A critical role of astrocytic IL-6-mediated paracrine growth promotion.
    Quan W; Xu CS; Ma C; Chen X; Yu DH; Li ZY; Wang DW; Tang F; Wan GP; Wan J; Wang ZF; Li ZQ
    Int Immunopharmacol; 2024 Sep; 139():112707. PubMed ID: 39032472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARγ Activation.
    Elkahloun AG; Rodriguez Y; Alaiyed S; Wenzel E; Saavedra JM
    Mol Neurobiol; 2019 May; 56(5):3193-3210. PubMed ID: 30105672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma.
    Nakano A; Hattori Y; Aoki C; Jojima T; Kasai K
    Hypertens Res; 2009 Sep; 32(9):765-9. PubMed ID: 19590508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.
    Tian Q; Miyazaki R; Ichiki T; Imayama I; Inanaga K; Ohtsubo H; Yano K; Takeda K; Sunagawa K
    Hypertension; 2009 May; 53(5):798-804. PubMed ID: 19289654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic stroke.
    Olschewski DN; Nazarzadeh N; Lange F; Koenig AM; Kulka C; Abraham JA; Blaschke SJ; Merkel R; Hoffmann B; Fink GR; Schroeter M; Rueger MA; Vay SU
    BMC Neurosci; 2024 Jun; 25(1):29. PubMed ID: 38926677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candesartan modulates microglia activation and polarization via NF-κB signaling pathway.
    Qie S; Ran Y; Lu X; Su W; Li W; Xi J; Gong W; Liu Z
    Int J Immunopathol Pharmacol; 2020; 34():2058738420974900. PubMed ID: 33237822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective mechanisms of telmisartan against hepatic ischemia/reperfusion injury in rats may involve PPARγ-induced TLR4/NF-κB suppression.
    Morsy MA; Abdel-Gaber SA; Rifaai RA; Mohammed MM; Nair AB; Abdelzaher WY
    Biomed Pharmacother; 2022 Jan; 145():112374. PubMed ID: 34915671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of tetramethylpyrazine and astragaloside IV on spinal cord injury via alteration of astrocyte A1/A2 polarization through the Sirt1-NF-κB pathway.
    Rao Y; Li J; Qiao R; Luo J; Liu Y
    Int Immunopharmacol; 2024 Apr; 131():111686. PubMed ID: 38461631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
    Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan attenuates hyperglycemia-exacerbated VCAM-1 expression and monocytes adhesion in TNFα-stimulated endothelial cells by inhibiting IKKβ expression.
    Song KH; Park JH; Jo I; Park JY; Seo J; Kim SA; Cho DH
    Vascul Pharmacol; 2016 Mar; 78():43-52. PubMed ID: 26455386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effect of IL-1 inhibition following lipopolysaccharide-induced neuroinflammation in neonatal microglia and astrocytes.
    Pierre WC; Londono I; Quiniou C; Chemtob S; Lodygensky GA
    Int J Dev Neurosci; 2022 May; 82(3):243-260. PubMed ID: 35315121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension.
    Li HB; Li X; Huo CJ; Su Q; Guo J; Yuan ZY; Zhu GQ; Shi XL; Liu JJ; Kang YM
    Toxicol Appl Pharmacol; 2016 Aug; 305():93-102. PubMed ID: 27292124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes.
    Pang T; Benicky J; Wang J; Orecna M; Sanchez-Lemus E; Saavedra JM
    J Hypertens; 2012 Jan; 30(1):87-96. PubMed ID: 22124178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
    Garrido-Gil P; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    J Neuroinflammation; 2012 Feb; 9():38. PubMed ID: 22356806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma.
    Walcher D; Hess K; Heinz P; Petscher K; Vasic D; Kintscher U; Clemenz M; Hartge M; Raps K; Hombach V; Marx N
    Hypertension; 2008 Feb; 51(2):259-66. PubMed ID: 18158351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin reduces LPS-induced A1 reactive astrocyte activation and inflammation via inhibiting p38-MAPK signaling pathway.
    Sun M; Song Y; Hu X; Zhang Z; Tan R; Cai Z; Wang X; Fu Y; You H; Cui S; Zhao W; An J; Chen X; Lu H
    Glia; 2025 Jan; 73(1):25-37. PubMed ID: 39310943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MFG-E8 reverses microglial-induced neurotoxic astrocyte (A1) via NF-κB and PI3K-Akt pathways.
    Xu X; Zhang A; Zhu Y; He W; Di W; Fang Y; Shi X
    J Cell Physiol; 2018 Jan; 234(1):904-914. PubMed ID: 30076715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan, an angiotensin II receptor blocker, attenuates Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-1β in murine macrophages.
    Choe SH; Choi EY; Hyeon JY; Keum BR; Choi IS; Kim SJ
    Int Immunopharmacol; 2019 Oct; 75():105750. PubMed ID: 31330445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.